Indivior PLC 8-K filings

Indivior PLC held its 2025 Annual General Meeting on May 8, 2025, with all resolutions duly passed by shareholders.

Indivior PLC reports first quarter 2025 results, with total net revenue of $266 million and reaffirms its FY 2025 guidance.

Indivior is seeking shareholder approval for a revised Directors Remuneration Policy at its upcoming Annual General Meeting to attract and retain top talent, particularly in the competitive US biopharmaceutical market, and to align CEO compensation with shareholder value creation.

Indivior PLC announces the appointment of Joe Ciaffoni as CEO, along with several board changes and an amended agreement with Oaktree Capital Management.